Relationship Between Metrnl Expression, IL-1β, and TNF-α in Patients With Peri-Implantitis
- Sponsor
- Ataturk University
- Study ID
- NCT07697729
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
Peri-implantitis is an inflammatory disease affecting the tissues around dental implants and may lead to progressive bone loss and implant failure. Current diagnosis is mainly based on clinical and radiographic findings, which may not fully reflect the underlying inflammatory activity. Therefore, there is a need for biological markers that may provide additional information about disease-related changes. This observational study aims to compare the levels of Meteorin-like protein (Metrnl) and selected inflammatory cytokines in peri-implant crevicular fluid obtained from individuals with peri-implantitis and individuals with healthy implants. The study will evaluate Metrnl, interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), and interleukin-10 (IL-10). It will also examine the relationships between Metrnl and these inflammatory markers. The study hypothesis is that Metrnl levels differ between healthy peri-implant tissues and peri-implantitis and are associated with pro-inflammatory and anti-inflammatory cytokine levels. The findings may help clarify the possible role of Metrnl in peri-implant inflammation and its potential as a biomarker for distinguishing peri-implant health from peri-implantitis.
Key Dates
- First listed
- Jul 13, 2026
- Start date
- Jul 7, 2026
- Status verified
- Jul 2026
- Primary completion
- Aug 1, 2026
- Completion
- Aug 2, 2026
Study Design
- Enrollment
- 60 participants (estimated)
Arms
- Arm: Peri-Implantitis GroupIndividuals diagnosed with peri-implantitis based on clinical and radiographic criteria. Peri-implant crevicular fluid samples will be collected, and Metrnl, IL-1β, TNF-α, and IL-10 levels will be evaluated.
- Arm: Peri-Implant Health GroupIndividuals with clinically and radiographically healthy peri-implant tissues. Peri-implant crevicular fluid samples will be collected, and Metrnl, IL-1β, TNF-α, and IL-10 levels will be evaluated.
Primary Outcome Measure
Metrnl Concentration in Peri-Implant Crevicular Fluid [ Time Frame: At enrollment ]
Central Contacts
- Pınar Eser Tuna, DDS+905063372525
Related Studies
- Surgical Treatment of Peri-implantitis Using a Bone Substitute With or Without a Resorbable Collagen MembraneEnrolling By Invitation · Andrea Ravida · Pittsburgh, Pennsylvania
- Experimental Peri-implant Mucositis on Implant Sites That Were Previously Treated With or Without ImplantoplastyEnrolling By Invitation · University of Pittsburgh · Pittsburgh, Pennsylvania
- Regenerative Treatment of Peri-implantitisEnrolling By Invitation · University of Michigan · Ann Arbor, Michigan
- Efficacy of Non-surgical and Surgical Surface Decontamination Methods on Peri-implantitis-affected ImplantsEnrolling By Invitation · Andrea Ravida · Pittsburgh, Pennsylvania